Analysis of pharmacistsí opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic

Acta Poloniae Pharmaceutica - Drug Research

Volumn 70, Issue 5, 2013, Pages 923-931

  Maly, Josef ^a   Dosedel, Martin ^a   Kubena, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Brand name drug; Generic drug; Generic substitution; Pharmacist

Indexed keywords

GENERIC DRUG;

ADULT; ADVERSE DRUG REACTION; ARTICLE; ATTITUDE; AWARENESS; CZECH REPUBLIC; DEMOGRAPHY; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PHARMACIST; QUESTIONNAIRE; SPECIALIZATION; AGE; AGED; DRUG LEGISLATION; DRUG SUBSTITUTION; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; ATTITUDE OF HEALTH PERSONNEL; CZECH REPUBLIC; DATA COLLECTION; DRUG SUBSTITUTION; DRUGS, GENERIC; FEMALE; HUMANS; LEGISLATION, DRUG; MALE; MIDDLE AGED; PHARMACISTS; QUESTIONNAIRES; SEX FACTORS;

EID: 84884221457     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Shrank W.H., Stedman M., Ettner S.L., DeLapp D., Dirstine J., Brookhart M.A., Fischer M.A., Avorn J., Asch S.M.: J. Gen. Intern. Med. 22, 9, 1298 (2007).
2. Economic information on health care 2010. Institute of Health Information and Statistics of the Czech Republic. Available at http://www.uzis.cz/en/ publications/economicinformation- health-care-2010 (accessed 25. 5. 2012).
3. Kreling, D.H., Mott, D.A., Wiederholt, J.B., Lundy J., Levitt, L. Prescription Drug Trends: A Chartbook. Henry J. Kaiser Family Foundation, July 2000 (update November 2001). Available at http://www.kff.org/rxdrugs/ loader.cfm?url=/commonspot/security/getfile.c fm&pageid=13796 (accessed 25. 5. 2012).
4. Directive 2004/27/EC of the European Parliament and the Council of 31 March 2004 amneding Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L 136/34. Available at http://ec.europa. eu/health/files/eudralex/vol-1/dir-2004- 27/ dir-2004-27-en.pdf (accessed 25. 5. 2012).
5. Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **. European Medicines Agency, 2010. Available at http://www.emea.europa.eu/docs/ en-GB/document-library/Scientific-guideline/ 2010/01/WC500070039.pdf. (accessed 25. 5. 2012).
6. Simoens S.: Int. J. Clin. Pharm. 33, 469 (2011).
7. A Primer. Generic Drugs, Patents and the Pharmaceutical Marketplace. National Institute for Health Care Management Foundation, 2002. Available at http://www.nihcm.org/pdf/GenericsPrimer. pdf (accessed 25. 5. 2012).
8. Kjoenniksen I., Lindbaek M., Granas A.G.: Pharm. World Sci. 28, 284 (2006).
9. Paraponaris A., Verger P., Desquins B., Villani P., Bouvenot G., Rochaix L., Gourheux J.C., Moatti J.P.; Panel M.G. Paca: Health Policy 70, 23 (2004).
10. Meredith P.: Clin. Ther. 25, 2875 (2003).
11. Czech Republic: Act No. 378/2007 on Pharmaceuticals. In: Catch III Registration of pharmaceuticals and steps related to their registration, Article 25. 115, 22-23 (2008) (in Czech).
12. Banahan B.F. 3rd, Kolassa E.M.: Arch. Intern. Med. 157, 2080 (1997).
13. Annual Report 2008. Czech Chambers of Pharmacists. Available at http://lekarnici.cz/ getattachment/O-CLnK/Vyrocni-zpravy/Vyrocni- zprava-za-rok-2008/Vyrocni-zprava- 2008.pdf.aspx (accessed 25. 5. 2012) (in Czech).
14. García A.J., Martos F., Leiva F., Sánchez de la Cuesta F.: Gac Sanit. 17, 144 (2003) (in Spanish).
15. Hassali M.A., Stewart K., Kong D.C.: Med. J. Aust. 188, 123 (2008).
16. Physicians, Dentists and Pharmacists 2008. Institute of Health Information and Statistics of the Czech Republic. Available at www.uzis.cz/ system/files/lekfar2008.pdf. (accessed 25. 5. 2012) (in Czech).
17. Chong C.P., Hassali M.A., Bahari M.B., Shafie A.A.: Int. J. Clin. Pharm. 33, 124 (2011).
18. Pearce G.A., McLachlan A.J., Ramzan I.: J. Pharm. Pract. Res. 34,195 (2004).
19. Nightingale S.L., Morrison J.C.: JAMA. 258, 1200 (1987).
20. Davit B.M., Nwakama P.E., Buehler G.J., Conner D.P., Haidar S.H., Patel D.T., Yang Y., Yu L.X., Woodcock J.: Ann. Pharmacother. 43, 1583 (2009).
21. Gomez Y., Adams E., Hoogmartens J.: J. Pharm. Biomed. Anal. 34, 341 (2004).
22. Kopečná E., Deščíková V., Vlček J., Mladá J.: Int. J. Clin. Pharm. 33, 683 (2011).
23. Reppe L.A., Stenberg-Nilsen H., Harg P., Hegge A.B., Lillefloth A.K., Buajordet I.: Tidsskr. Nor. Laegeforen 128, 2696 (2008).
24. Thorn F., Celius H., Odegård T., Mandla R., Hexeberg E.: Clin. Mol. Allergy 9, 5 (2011).
25. Mumoli N., Cei M., Luschi R., Carmignani G., Camaiti A.: QJM 104, 709 (2011).
26. Dueñas-Laita A., Pineda F., Armentia A.: N. Engl. J. Med. 361, 1317 (2009).
27. Chandeclerc M.L., Tréchot P., Martin S., Weber-Muller F., Schmutz J.L., Barbaud A.: Allergy 61, 1492 (2006).
28. Kesselheim A.S., Stedman M.R., Bubrick E.J., Gagne J.J., Misono A.S., Lee J.L., Brookhart M.A., Avorn J., Shrank W.H.: Drugs 70, 605 (2010).
29. Borgheini G.: Clin. Ther. 25, 1578 (2003).
30. Osterberg L., Blaschke T.: N. Engl. J. Med. 353, 4877 (2005).
31. Puig-Junoy J.: Pharmacoeconomics 28, 649 (2010).
32. Aalto-Setälä V.: Eur. J. Health Econ. 9, 185 (2008).
33. Allenet B., Barry H.: Pharm. World Sci. 25, 197 (2003).
34. Krähenbühl J.M., Kremer B., Guignard B., Bugnon O.: Pharm. World Sci. 30, 777 (2008).
35. Anonymous: The physician's and pharmacist's roles derived from the new Act on Pharmaceuticals: Pharmacotherapeutic information 2/2008. A monthly for physicians and pharmacists. State Institute for Drug Control, 2, 1-4 (2008) (in Czech).
36. Johnston A., Asmar R., Dahlöf B., Hill K., Jones D.A., Jordan J., Livingston M., Macgregor G., Sobanja M., Stafylas P., Rosei E.A., Zamorano J.: Br. J. Clin. Pharmacol. 72, 727 (2011).
37. Duerden M.G., Hughes D.A.: Br. J. Clin. Pharmacol. 70, 335 (2010).
38. Bioequivalence and labelling of medicines with regard to generic substitution. Available at http:// laegemiddelstyrelsen.dk/en/topics/ authorisation- and-supervision/licensing-of-medicines/ marketing-authorisation/ application-formarketing- authorisation/bioequivalence-andlabelling- of-medicine-bstitution.aspx. (accessed 25. 5. 2012).